Takahiro Shibayama

Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-?-d-ARABINO-Pentofuranosyl) cytosine) and itsN4-palmitoyl derivative (CS-682)

Kenji Hanaoka, Masako Suzuki, Tomowo Kobayashi et al. · International Journal of Cancer · 1999 · 59 citations · Full text

In Vitro and In Vivo Antibacterial Activities of CS-023 (RO4908463), a Novel Parenteral Carbapenem

Tetsufumi Koga, Tomomi Abe, Harumi Inoue et al. · Antimicrobial Agents and Chemotherapy · 2005 · 53 citations · Full text

Antimicrobial Susceptibility, Health Sciences, Antibiotics +15

Screening of <scp>BCOR</scp>‐<scp>CCNB</scp>3 sarcoma using immunohistochemistry for <scp>CCNB</scp>3: A clinicopathological report of three pediatric cases

Takahiro Shibayama, Takeshi Okamoto, Yasuaki Nakashima et al. · Pathology International · 2015 · 43 citations

Tumor Biology, Bone Sarcomas, Surgical Oncology +15

Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases

Takahiro Shibayama, Naohiro Makise, Toru Motoi et al. · The American Journal of Surgical Pathology · 2021 · 41 citations

Clinicopathologic Characterization, Tfe3 Subtype, Medicine +12

Characterization of CS-023 (RO4908463), a Novel Parenteral Carbapenem Antibiotic, and Meropenem as Substrates of Human Renal Transporters

Takahiro Shibayama, Daisuke Sugiyama, Emi Kamiyama et al. · Drug Metabolism and Pharmacokinetics · 2007 · 39 citations